Insider · CIK 0001379970

Gilman Steven C

CIK 0001379970 Name as filed on the most recent filing

Filed as Gilman Steven C (43)

51 transaction lines · from 43 filings · filed 2010-05-18 to 2024-10-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

51 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-10-16 S, Open-market sale Vericel CorpVCEL 241,253, disposed Open Form 4 filing 0001140361-24-043695
2024-10-02 S, Open-market sale Vericel CorpVCEL 235,362, disposed Open Form 4 filing 0001140361-24-042882
2024-09-18 S, Open-market sale Vericel CorpVCEL 265,680, disposed Open Form 4 filing 0001140361-24-041562
2024-09-04 S, Open-market sale Vericel CorpVCEL 242,900, disposed Open Form 4 filing 0001140361-24-040228
2022-06-03 S, Open-market sale Akebia Therapeutics, Inc.AKBA 1,653, disposed Open Form 4 filing 0001562180-22-004870
2022-04-29 S, Open-market sale Vericel CorpVCEL 27,846, disposed Open Form 4 filing 0001593968-22-000897
2021-11-29 S, Open-market sale Vericel CorpVCEL 195,855, disposed Open Form 4 filing 0001593968-21-002478
2021-10-27 S, Open-market sale Vericel CorpVCEL 252,870, disposed Open Form 4 filing 0001593968-21-002304
2021-09-30 S, Open-market sale Vericel CorpVCEL 244,255, disposed Open Form 4 filing 0001593968-21-002214
2021-06-07 S, Open-market sale Akebia Therapeutics, Inc.AKBA 15,163, disposed Open Form 4 filing 0001562180-21-004152
2020-12-21 P, Open-market purchase Scynexis IncSCYX 25,000, acquired Open Form 4 filing 0001209191-20-064956
2020-08-05 S, Open-market sale Momenta Pharmaceuticals IncMNTA 425,750, disposed Open Form 4 filing 0001179110-20-008799
2020-07-29 S, Open-market sale Momenta Pharmaceuticals IncMNTA 297,000, disposed Open Form 4 filing 0001179110-20-008585
2020-07-22 S, Open-market sale Momenta Pharmaceuticals IncMNTA 332,300, disposed Open Form 4 filing 0001179110-20-008471
2020-06-08 S, Open-market sale Akebia Therapeutics, Inc.AKBA 55,169, disposed Open Form 4 filing 0001562180-20-004359
2019-11-20 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 19,894, acquired Open Form 4 filing 0001562180-19-005642
2019-05-01 S, Open-market sale Vericel CorpVCEL 126,095, disposed Open Form 4 filing 0001593968-19-001035
2019-02-28 S, Open-market sale Vericel CorpVCEL 135,129, disposed Open Form 4 filing 0001593968-19-000610
2018-12-03 S, Open-market sale Vericel CorpVCEL 150,908, disposed Open Form 4 filing 0001593968-18-001531
2018-09-04 S, Open-market sale Vericel CorpVCEL 108,270, disposed Open Form 4 filing 0001593968-18-001169
2018-06-22 S, Open-market sale Momenta Pharmaceuticals IncMNTA 49,321, disposed Open Form 4 filing 0001179110-18-009059
2018-06-11 S, Open-market sale Keryx Biopharmaceuticals IncKERX 6,830, disposed Open Form 4 filing 0001114220-18-000062
2018-05-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 6,958, disposed Open Form 4 filing 0001114220-18-000059
2017-07-25 P, Open-market purchase Contrafect CorpCFRX 992, acquired Open Form 4 filing 0001209191-17-046310
2016-07-27 P, Open-market purchase Contrafect CorpCFRX 49,600, acquired Open Form 4 filing 0001209191-16-134126
2014-10-01 S, Open-market sale Cubist Pharmaceuticals IncCBST 3 lines 3,146,710, disposed Open Form 4 filing 0001127602-14-029076
2014-07-28 S, Open-market sale Cubist Pharmaceuticals IncCBST 2 lines 2,501,104, disposed Open Form 4 filing 0001127602-14-024045
2014-05-15 S, Open-market sale Cubist Pharmaceuticals IncCBST 3 lines 1,108,240, disposed Open Form 4 filing 0001127602-14-017670
2014-05-14 S, Open-market sale Cubist Pharmaceuticals IncCBST 115,920, disposed Open Form 4 filing 0001127602-14-017474
2014-02-18 S, Open-market sale Cubist Pharmaceuticals IncCBST 198,375, disposed Open Form 4 filing 0001127602-14-007067
2014-01-02 S, Open-market sale Cubist Pharmaceuticals IncCBST 2 lines 1,695,443, disposed Open Form 4 filing 0001127602-14-000159
2014-01-02 S, Open-market sale Cubist Pharmaceuticals IncCBST 2 lines 1,695,443, disposed Open Form 4 filing 0001127602-14-000151
2013-06-03 S, Open-market sale Cubist Pharmaceuticals IncCBST 824,204, disposed Open Form 4 filing 0001127602-13-019124
2013-05-16 S, Open-market sale Cubist Pharmaceuticals IncCBST 58,700, disposed Open Form 4 filing 0001127602-13-017258
2013-05-15 S, Open-market sale Cubist Pharmaceuticals IncCBST 49,238, disposed Open Form 4 filing 0001127602-13-017086
2013-05-14 S, Open-market sale Cubist Pharmaceuticals IncCBST 55,818, disposed Open Form 4 filing 0001127602-13-016917
2013-02-19 S, Open-market sale Cubist Pharmaceuticals IncCBST 51,047, disposed Open Form 4 filing 0001127602-13-006939
2013-01-02 S, Open-market sale Cubist Pharmaceuticals IncCBST 644,745, disposed Open Form 4 filing 0001127602-13-000546
2012-05-17 S, Open-market sale Cubist Pharmaceuticals IncCBST 831,466, disposed Open Form 4 filing 0001127602-12-017232
2012-05-16 S, Open-market sale Cubist Pharmaceuticals IncCBST 33,396, disposed Open Form 4 filing 0001127602-12-017000
2012-05-15 S, Open-market sale Cubist Pharmaceuticals IncCBST 33,479, disposed Open Form 4 filing 0001127602-12-017000
2012-05-14 S, Open-market sale Cubist Pharmaceuticals IncCBST 47,162, disposed Open Form 4 filing 0001127602-12-016878
2011-10-26 S, Open-market sale Cubist Pharmaceuticals IncCBST 2,757,596, disposed Open Form 4 filing 0001127602-11-027824

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 47
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GILMAN STEVEN C, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001379970

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.